An adverse reaction is a harmful or unintended response associated with the use of a medicinal product or medical treatment, where a causal relationship to the product is at least suspected. In life science translation, the term appears in safety reports, labeling, clinical study documents, and pharmacovigilance content, where it must be clearly distinguished from adverse events that are not attributed to the product and from expected side effects.
In translation, adverse reaction appears in safety narratives, clinical study reports, labeling, and pharmacovigilance submissions. It is usually handled during case processing, aggregate report localization, and patient-facing label updates. The wording must preserve distinctions between serious and non-serious reactions, expectedness, and the stated causal relationship, because these differences affect how safety information is interpreted by regulators and clinicians.
A common pitfall is collapsing adverse reaction, adverse event, and side effect into a single translation, which obscures whether a causal relationship is suspected. Another error is incorrectly grading severity or seriousness, distorting safety narratives and label warnings. Such shifts can affect regulatory assessment, harmonization of safety data, and patient risk communication.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →